Macrocyclics

Macrocyclics

Biotechnology, 700 Klein Rd, Plano, Texas, 75074, United States, 11-50 Employees

macrocyclics.com

  • twitter
  • LinkedIn

phone no Phone Number: +14*********

Who is MACROCYCLICS

Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and...

Read More

map
  • 700 Klein Rd, Plano, Texas, 75074, United States Headquarters: 700 Klein Rd, Plano, Texas, 75074, United States
  • 1998 Date Founded: 1998
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325998 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MACROCYCLICS

Macrocyclics Org Chart and Mapping

Employees

Paul Jurek

Director of Custom Product Development

Duke Halloran

Production Manager, Business Development Lead

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Macrocyclics

Answer: Macrocyclics's headquarters are located at 700 Klein Rd, Plano, Texas, 75074, United States

Answer: Macrocyclics's phone number is +14*********

Answer: Macrocyclics's official website is https://macrocyclics.com

Answer: Macrocyclics's revenue is $5 Million to $10 Million

Answer: Macrocyclics's SIC: 2834

Answer: Macrocyclics's NAICS: 325998

Answer: Macrocyclics has 11-50 employees

Answer: Macrocyclics is in Biotechnology

Answer: Macrocyclics contact info: Phone number: +14********* Website: https://macrocyclics.com

Answer: Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine. We provide a broad library of catalog products designed to meet the needs of our basic and applied research customers as well as custom cGMP products and services to accelerate early stage clinical development programs. We also offer expert consulting services related to fundamental chelation chemistry and bioconjugation. Macrocyclics has a cutting-edge research and development strategy geared toward meeting the emerging needs of the medical community with both commercial and academic collaborations in mind. Our molecular imaging platform technology is adaptable to a broad range of radionuclides such as copper 64, gallium 68 and zirconium 89 for positron emission tomography (PET) and gadolinium and other lanthanide ions for optical and magnetic resonance imaging (MRI). Our products include an extensive line of bifunctional ligands designed specifically for bio-targeting in combination with monoclonal antibodies and peptide fragments. Since 1996, Macrocyclics has been the most trusted name in metal-ligand chelating technologies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access